Literature DB >> 9413060

Efficacy of prostaglandin I2 analog on liver grafts subjected to 30 minutes of warm ischemia.

A Kishida1, Y Kurumi, M Kodama.   

Abstract

Due to the fact that no effective conditioning agent for hemodynamically unstable donors exists, the number of suitable donors is limited. The efficacy of OP-41483, a stable analog of prostaglandin I2, as a conditioning agent of the liver was investigated in this study using pigs. OP-41483 was administered via the portal tributary for 10 min before 30 min of warm ischemia. Graft livers were procured after perfusion with OP-41483 in cold normal saline, then flushed with OP-41483 in Euro-Collins solution and placed in cold storage prior to orthotopic transplantation. OP-41483 was also administered intraportally for 120 min after reperfusion. Biochemical and histological studies, and survival rates were compared with a control group not given OP-41483 in an otherwise similar experimental protocol. The graft function recovered better in the OP group than in the control group, shown by the lactate values and lactate-to-pyruvate ratios. The marked congestion noted in the parenchyma of the control group livers was minimal in the OP group, verifying the microcirculatory effect of prostaglandin I2 by its vasodilatory and antithrombotic actions. These findings suggest that OP-41483 has some protective effect as a conditioning agent in liver transplantation, with timing of administration being crucial.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413060     DOI: 10.1007/bf02385788

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

1.  PGE1 reduces injury in hepatic allografts following preservation.

Authors:  K M Olthoff; E Wasef; P Seu; D K Imagawa; J A Freischlag; J Hart; R W Busuttil
Journal:  J Surg Res       Date:  1991-06       Impact factor: 2.192

2.  Protective effect of PGI2 and diltiazem on liver ischemia and reperfusion in pigs.

Authors:  R Steininger; F Mühlbacher; R Rauhs; E Roth; W Bursch
Journal:  Transplant Proc       Date:  1988-10       Impact factor: 1.066

3.  Treatment of primary liver graft nonfunction with prostaglandin E1.

Authors:  P D Greig; G M Woolf; S B Sinclair; M Abecassis; S M Strasberg; B R Taylor; L M Blendis; R A Superina; M F Glynn; B Langer
Journal:  Transplantation       Date:  1989-09       Impact factor: 4.939

4.  Prostaglandin protection of human isolated gastric glands against indomethacin and ethanol injury. Evidence for direct cellular action of prostaglandin.

Authors:  A Tarnawski; T Brzozowski; I J Sarfeh; W J Krause; T R Ulich; H Gergely; D Hollander
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

5.  Conversion of mitochondrial redox state toward oxidation by prostacyclin in 70%-hepatectomized rats.

Authors:  T Morimoto; K Ozawa; W Isselhard
Journal:  Res Exp Med (Berl)       Date:  1992

6.  Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.

Authors:  B Fujitani; K Wakitani
Journal:  Jpn J Pharmacol       Date:  1990-05

7.  Prostaglandin I2 attenuates ischemic acute renal failure in the rat.

Authors:  M D Lifschitz; J L Barnes
Journal:  Am J Physiol       Date:  1984-11

8.  Vasodilator prostaglandins (PG) prevent renal damage after ischemia.

Authors:  R P Kaufman; H Anner; L Kobzik; C R Valeri; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

9.  Hepatoprotective effects of prostacyclins on CCl4-induced liver injury in rats.

Authors:  A Divald; E Ujhelyi; A Jeney; K Lapis; L Institoris
Journal:  Exp Mol Pathol       Date:  1985-04       Impact factor: 3.362

10.  Prostaglandin E1 attenuation of ischemic renal reperfusion injury in the rat.

Authors:  A V Vargas; V Krishnamurthi; R Masih; A V Robinson; J A Schulak
Journal:  J Am Coll Surg       Date:  1995-06       Impact factor: 6.113

View more
  1 in total

1.  Nitric oxide and prostaglandins potentiate the liver regeneration cascade.

Authors:  Jodi M Schoen Smith; W Wayne Lautt
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.